Metropath Diagnostics Private Limited
About Metropath Diagnostics Private Limited
Data last updated:
Metropath Diagnostics Private Limited is a private limited company based in Kaithal, Haryana, India. It was incorporated on 07 June 2024.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U86905HR2024PTC122344.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kavita and Satish Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No. 301 Block No. 75, Vill – Rajound Teh – Kaithal, Haryana, India – 136044.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.4 Lakh. For the same year it recorded a net loss of ₹11.3 Lakh (net margin -34.9%) and EBITDA of -₹10.33 Lakh (EBITDA margin -31.9%).
Company details
Contact details
Metropath Diagnostics Private Limited's registered office is in Kaithal, Haryana.
- Registered AddressH. No. 301 Block No. 75, Vill – Rajound Teh – Kaithal, Haryana, India – 136044
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Metropath Diagnostics Private Limited
FY 2025 filings availableMetropath Diagnostics Private Limited reported revenue of ₹32.4 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹10.33 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹11.3 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -31.9% |
| Net Profit Margin | -34.9% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Metropath Diagnostics Private Limited, buy the company report.
Board of directors of Metropath Diagnostics Private Limited
Metropath Diagnostics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavita Also directs: Mediverse Diagnostics Private Limited | Director | 07 Jun 2024 | 2 Years 4 Months | Current |
| Satish Kumar | Director | 07 Jun 2024 | 2 Years 4 Months | Current |
Peer comparison
Metropath Diagnostics Private Limited is compared with the 10 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Family Health Providers Private Limited | ₹33.01 Lakh (FY 2024) | -86.0% | Bangalore, Karnataka, India | |||
| Dr. Sarwan Diagnostic Labs Private Limited | ₹32.8 Lakh (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Radquest Teleradiology Services Private Limited | ₹32.77 Lakh (FY 2016) | Hyderabad, Telangana, India | ||||
| Rigero Medical Services Private Limited | ₹32.53 Lakh (FY 2025) | -46.0% | Mumbai, Maharashtra, India | |||
| Pooram Engineering Private Limited | ₹32.5 Lakh (FY 2017) | -82.0% | Parippally, Kerala, India | |||
| Metropath Diagnostics Private Limitedthis company | ₹32.4 Lakh (FY 2025) | -₹11.3 Lakh | -34.9% | Kaithal, Haryana, India | ||
| Dna Xperts Private Limited | ₹32.34 Lakh (FY 2023) | -86.0% | Delhi, India | |||
| Sequel Diagnostic Services Private Limited | ₹32.34 Lakh (FY 2022) | 95.0% | Gurgaon, Haryana, India | |||
| Bioq Healthcare Private Limited | ₹32.3 Lakh (FY 2024) | 31.0% | Hajipur, Bihar, India | |||
| Harrison Miller Healthcare Private Limited | ₹32.2 Lakh (FY 2025) | -87.0% | Kozhikode, Kerala, India | |||
| Crystal Imaging Private Limited | ₹31.68 Lakh (FY 2019) | 914.0% | Kalyan, Maharashtra, India |
To see the full peer comparison of Metropath Diagnostics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Metropath Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metropath Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Metropath Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Metropath Diagnostics Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Kavita was appointed as Director on 07 Jun 2024.
Frequently asked questions
Metropath Diagnostics is an active private limited company based in Kaithal, Haryana, India. It was incorporated on 07 June 2024 (2+ years old) and is registered under CIN U86905HR2024PTC122344.
Metropath Diagnostics has 2 current directors:
- Kavita - Director
- Satish Kumar - Director
The latest financial statements of Metropath Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Metropath Diagnostics is U86905HR2024PTC122344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metropath Diagnostics was incorporated on 07 June 2024, making it 2+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Metropath Diagnostics by revenue are Family Health Providers Private Limited, Dr. Sarwan Diagnostic Labs Private Limited, Radquest Teleradiology Services Private Limited, Rigero Medical Services Private Limited, Pooram Engineering Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Kavita was appointed as Director on 07 Jun 2024. Satish Kumar was appointed as Director on 07 Jun 2024.
The registered office of Metropath Diagnostics is at H. No. 301 Block No. 75, Vill – Rajound Teh – Kaithal, Haryana, India – 136044.
Metropath Diagnostics can be reached at its registered office: H. No. 301 Block No. 75, Vill – Rajound Teh – Kaithal, Haryana, India – 136044.
Metropath Diagnostics is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.